New York, USA, Aug. 23, 2021 (GLOBE NEWSWIRE) — Facial Rejuvenation Market Overview:
According to a comprehensive research report by Market Research Future (MRFR), “Facial Rejuvenation Market Information By Product Type, End-User and Region Forecast till 2027” the market is expected to reach USD 27,110.43 Million at 20.65% CAGR by 2027.
Market Scope:
Facial rejuvenation is a cosmetic surgery that restores skin elasticity and improves the appearance of the skin using non-invasive or minimally invasive methods.
Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/8811
Competitive Landscape
The notable players of the market are:
- Allergan (Ireland)
- Merz Pharma (Germany)
- Galderma (Switzerland)
- Lumenis (US)
- Revance (US)
- Contura Ltd (US)
- Anika Therapeutics Inc. (US)
- Fibrocell Science Inc. (US)
- Cynosure, A Hologic Company (US)
- Daewoong Co. Ltd (South Korea)
- Sinclair Pharma (UK)
- Teoxane Laboratories (Switzerland)
- Suneva Medical (US)
- Solta Medical a Subsidiary of Bausch Health Companies (US)
Market Drivers
The market for facial rejuvenation is being boosted by increased economic prosperity and disposable incomes all around the world. Changing lifestyles, which often result in early aging, necessitate the need for rejuvenation procedures in order to stay competitive. The market is predicted to increase due to rising demand for non-invasive aesthetic operations,…
